GlassScriptPhysician profile
Ayesha Khan
NPI 1891036885
$3,030.58
in general payments reported to CMS, 2019-2025
24 companies · $1,853 in 2025
The $1,853 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $137 · 2021: $20.40 · 2022: $245 · 2023: $326 · 2024: $130 · 2025: $1,853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971 · Travel and Lodging: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,971.18 |
| Travel and Lodging | $337.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $877.42 | 2025 | General - Therapies, Avvigo Guidance System, General - Vascular Access |
| Edwards Lifesciences Corporation | $450.31 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Janssen Pharmaceuticals, INC | $300.31 | 2019-2023 | Xarelto |
| Shockwave Medical, INC | $231.14 | 2025 | |
| Heartflow, INC. | $159.50 | 2023-2024 | Ffrct |
| Gilead Sciences, INC. | $148.04 | 2023-2025 | Veklury |
| Medtronic, INC. | $136.60 | 2025 | Corevalve Evolut R |
| Pfizer INC. | $124.42 | 2019-2025 | |
| Stryker Corporation | $93.73 | 2025 | Flowtriever |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.50 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $62.37 | 2019-2020 | |
| Mylan Specialty L.P. | $60.98 | 2019-2022 | |
| Abiomed | $54.81 | 2023 | Impella |
| Allergan, INC. | $33.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.85 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $27.88 | 2020 | |
| Teleflex LLC | $25.59 | 2025 | Guideliner |
| Bard Access Systems, INC. | $25.08 | 2019 | |
| Abbott Laboratories | $24.48 | 2024 | Perclose Prostyle |
| Masimo Corporation | $24.41 | 2022 | |
| Smith+Nephew, INC. | $22.41 | 2022 | |
| Mallinckrodt Enterprises LLC | $21.80 | 2019 | |
| Vyera Pharmaceuticals, LLC | $18.14 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.06 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.